Prescient Therapeutics Ltd
(ASX:PTX)
A$
0.041
0 (0%)
Market Cap: 33.02 Mil
Enterprise Value: 18.84 Mil
PE Ratio: 0
PB Ratio: 1.86
GF Score: 0/100 Prescient Therapeutics Ltd Investor Presentation Transcript
Sep 27, 2022 / 02:00AM GMT
Release Date Price:
A$0.18
Patrick Nelson
Reach Markets Pvt Ltd - Moderator
Presentation
Sep 27, 2022 / 02:00AM GMT
=====================
Corporate Participants
=====================
* Steven Yatomi-Clarke
Prescient Therapeutics Limited - CEO, MD
* Rebecca Lim
Prescient Therapeutics Limited - Senior VP, Scientific Affairs
=====================
Conference Call Participants
=====================
* Patrick Nelson
Reach Markets Pvt Ltd - Moderator
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot